Antidiabetic Properties of Low-Molecular-Weight BDNF Mimetics Depend on the Type of Activation of Post-Receptor Signaling Pathways
- 6 Downloads
Reduced proliferation and enhanced apoptosis of β cells in diabetes mellitus are associated with a deficiency of brain-derived neurotrophic factor (BDNF). Low-molecular weight compounds similar to different BDNF loops were synthesized at the V. V. Zakusov Research Institute of Pharmacology. They produce a potentiating effect on TrkB phosphorylation, but differently activate post-receptor signaling pathways. We compared their effects on the severity of streptozotocin-induced diabetes mellitus in C57Bl/6 mice. The antidiabetic effect (estimated from the degree of hyperglycemia and dynamics of body weight) was typical of GSB-214 compound that selectively activates PI3K/Akt. This activity was not revealed in GTS-201, selective activator of MAPK/Erk. GSB-106 compound activating both signaling pathways exhibited weak antidiabetic activity. Our results indicate that the antidiabetic effect is mainly related to activation of the PI3K/Akt signaling pathway.
Key Wordsdiabetes C57Bl/6 mice streptozotocin low-molecular-weight BDNF mimetics
Unable to display preview. Download preview PDF.
- 1.Gudasheva TA, Antipova TA, Konstantinopolsky MA, Povarnina PY, Seredenin SB. Nerve growth factor novel dipeptide mimetic GK-2 selectively activates TrkA postreceptor signaling pathways and does not cause adverse effects of native neurotrophin. Dokl. Biochem. Biophysics. 2014;456(1):88-91.Google Scholar
- 2.Gudasheva TA, Antipova TA, Seredenin SB. Novel low-molecular-weight mimetics of the nerve growth factor. Dokl. Biochem. Biophysics. 2010;434(1):262-265.Google Scholar
- 3.Gudasheva TA, Tarasyuk AB, Pomogaibo SV, Logvinov IO, Povarnina PYu, Antipova TA, Seredenin SB. Design and synthesis of dipeptide mimetics of the brain neurotrophic factor. Bioorgan. Khimiya. 2012;38(3):280-290.Google Scholar
- 6.Patent RU No. 2613314. Small molecules with ngf-like activity and antidiabetic properties. Bull. No. 8. Published March 15, 2017.Google Scholar
- 12.Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2007;50(2):431-438.CrossRefPubMedGoogle Scholar
- 15.Yanev S, Aloe L, Fiore M, Chaldakov GN. Neurotrophic and metabotrophic potential of nerve growth factor and brain-derived neurotrophic factor: Linking cardiometabolic and neuropsychiatric diseases. World J. Pharmacol. 2013;2(4):92-99.Google Scholar